These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33312386)
1. Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma. Lv Y; Jin P; Chen Z; Zhang P Am J Transl Res; 2020; 12(11):7510-7527. PubMed ID: 33312386 [TBL] [Abstract][Full Text] [Related]
2. Exploring the Shared Gene Signatures and Molecular Mechanisms between Bladder Urothelial Carcinoma and Metabolic Syndrome. Li C; Wan Z; Deng Q; Li Z; Wang Y Arch Esp Urol; 2023 Oct; 76(8):605-621. PubMed ID: 37960960 [TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes. Qiu H; Hu X; He C; Yu B; Li Y; Li J Front Genet; 2020; 11():12. PubMed ID: 32117435 [TBL] [Abstract][Full Text] [Related]
4. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma. Zhang B; Wang Q; Fu C; Jiang C; Ma S Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746 [TBL] [Abstract][Full Text] [Related]
5. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer. Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T Front Genet; 2021; 12():696912. PubMed ID: 34512722 [No Abstract] [Full Text] [Related]
6. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720 [TBL] [Abstract][Full Text] [Related]
8. A Bioinformatic Analysis of Immune-Related Prognostic Genes in Clear Cell Renal Cell Carcinoma Based on TCGA and GEO Databases. Li J; Cao J; Li P; Deng R; Yao Z; Ying L; Tian J Int J Gen Med; 2022; 15():325-342. PubMed ID: 35035230 [TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis. Xing P; Jiang Z; Liu Y BMC Cancer; 2022 Aug; 22(1):926. PubMed ID: 36030212 [TBL] [Abstract][Full Text] [Related]
10. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma. Wan Z; Wang Y; Li C; Zheng D Open Life Sci; 2023; 18(1):20220682. PubMed ID: 37588995 [TBL] [Abstract][Full Text] [Related]
11. Robust pyroptosis risk score guides the treatment options and predicts the prognosis of bladder carcinoma. Deng D; Liu F; Liu Z; Wu Z; He Y; Zhang C; Zu X; Ou Z; Wang Y Front Immunol; 2022; 13():965469. PubMed ID: 36090967 [TBL] [Abstract][Full Text] [Related]
12. A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration. Luan JC; Zeng TY; Zhang QJ; Xia DR; Cong R; Yao LY; Song LB; Zhou X; Zhou X; Chen X; Xia JD; Song NH Cancer Cell Int; 2021 Aug; 21(1):414. PubMed ID: 34362387 [TBL] [Abstract][Full Text] [Related]
13. Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer. Liu S; Chen H; Zheng Z; He Y; Yao X Bioengineering (Basel); 2023 Mar; 10(3):. PubMed ID: 36978709 [No Abstract] [Full Text] [Related]
14. Comprehensive Exploration of Tumor Microenvironment Modulation Based on the ESTIMATE Algorithm in Bladder Urothelial Carcinoma Microenvironment. Chen J; Lv B; Zhan Y; Zhu K; Zhang R; Chen B; Jin Y; Li Y; Zheng J; Lin C Front Oncol; 2022; 12():724261. PubMed ID: 35237505 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma. Li H; Mo Z Int J Gen Med; 2021; 14():6885-6898. PubMed ID: 34703293 [TBL] [Abstract][Full Text] [Related]
16. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients. Wang L; Wei Q; Zhang M; Chen L; Li Z; Zhou C; He M; Wei M; Zhao L Int Immunopharmacol; 2020 Oct; 87():106795. PubMed ID: 32707495 [TBL] [Abstract][Full Text] [Related]
17. An innovative risk index based on neutrophils and macrophages can effectively predict prognosis and immunotherapy response in patients with muscle-invasive bladder cancer. Zhang X; Zhang A; Hu L; Xiong W; Shang P Transl Cancer Res; 2023 Mar; 12(3):536-549. PubMed ID: 37033357 [TBL] [Abstract][Full Text] [Related]
18. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma. Zhang C; Shen L; Qi F; Wang J; Luo J J Cell Physiol; 2020 Apr; 235(4):3849-3863. PubMed ID: 31596511 [TBL] [Abstract][Full Text] [Related]
19. Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial Cancer. Xu C; Song L; Peng H; Yang Y; Liu Y; Pei D; Guo J; Liu N; Liu J; Li X; Li C; Kang Z Front Mol Biosci; 2022; 9():963455. PubMed ID: 35936781 [No Abstract] [Full Text] [Related]
20. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer. Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]